Heterogenous Expression of CD15 in Acute Lymphoblastic Leukemia: A Study of Ten Anti-CD15 Monoclonal Antibodies in 158 Patients

References

• Vaickus L., Ball E. D., Foon K. A. Immune markers in hematologic malignancies. Critical Reviews in Oncology/Hematology 1991; 11: 267–297
   PubMed Web of Science ®Google Scholar
• Garand R., Vannier J. P., Béné M. C., Faure G., Bernard A., The GEIL. Correlations between acute lymphoid leukemia immunophenotype and clinical and laboratory data at presentation. Cancer. 1989; 64: 1437–1446
   PubMed Web of Science ®Google Scholar
• Knapp W., Strobl H., Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry (Communications in Clinical Cytometry) 1994; 18: 187–198
   Web of Science ®Google Scholar
• Béné M. C., Castoldi G., Knapp W., Ludwig W. D., Matutes E., Orfao A., Van't Veer M. B., For the European Group for the immunological characterisation of leukaemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia, in press
   Web of Science ®Google Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffin J. D., Collins H., Nelson D. A., Bloomfield C. D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic. leukemia. New England Journal of Medicine 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Mirro J., Zipf T. F., Pui C. H., Kitchingman G., Williams D., Melvin S., Murphy S. B., Stass S. Acute mixed lineage leukemia, clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
   PubMed Web of Science ®Google Scholar
• Basso G., Putti M. C., Cantu-Rajnoldi A., Saitta M., Santostasi T., Santoro N., Lippi A., Comelli A., Felici L., Favre C., Russo Mancuso G., Guglielmi C., Paolucci P., Biondi A., Rondelli R., Pession A. The immunophenotype in infant acute lymphoblastic leukaemia, correlation with clinical outcome. An Italian multicentre study (AIEOP). British Journal of Haematology 1992; 81: 184–191
   PubMed Web of Science ®Google Scholar
• Philip P. M., Monpoux F., Sudaka I., Baudoin F., Bayle J., Béné M. C., Faure G. C., The GEIL. Multiphenotypic acute leukemias, clinicopathologic correlations and response to therapy. Leukemia and Lymphoma 1992; 7: 489–495
   PubMed Web of Science ®Google Scholar
• Bucchieri V., Matutes E., Dyer M. J. S., Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7: 919–927
   PubMed Web of Science ®Google Scholar
• Garand R., Béné M. C., The GEIL. A new approach of acute lymphoblastic leukemia immunophenotypic classification, 1984–1994 the GEIL experience. Leukemia and Lymphoma 1994; 13: 1–5, (supp 1)
   PubMed Web of Science ®Google Scholar
• Howard M. R., Thomas L., Reid M. M. Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia. Journal of Clinical Pathology 1994; 47: 1006–1009
   PubMed Web of Science ®Google Scholar
• Hogg N., Horton M. A. Myeloid antigens, new and previouly defined clusters. Leucocyte Typing III, A. J. McMichael. Oxford University Press. 1987; 576–602
   Google Scholar
• Huang L. C., Civin C. I., Magnani J. L., Shaper J. H., Ginsburg V. My-1, the human myeloid specific antigen detected by mouse monoclonal antibodies is a sugar sequence found in lacto-N-fucopentaose III. Blood 1983; 61: 1020–1023
   PubMed Web of Science ®Google Scholar
• Geller R., Zahurak M., Hurwitz C., Burke P., Karp J., Piantadosi S., Civin C. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia, the significance of the stem-cell glycoprotein CD34 (My10). British Journal of Haematology 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Solary E., Casanovas R. O., Campos L., Béné M. C., Faure G., Maingon P., Falkenrodt A., Lenormand B., Genetet N., The GEIL. Surface markers in adult acute myeloblastic leukemia, correlation of CD19+, CD34+, and CD14+/DR-phenotypes with short survival. Leukemia 1992; 6: 393–399
   PubMed Web of Science ®Google Scholar
• Guyotat D., Campos L., Shi Z. H., Charin C., Treille D., Magaud J. P., Fière D. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 1990; 4: 664–666
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Head D. R., Schell M. J., Rivera G. K., Mirro J., Crist W., Behm F. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991; 78: 1327–1337
   PubMed Web of Science ®Google Scholar
• Cantu-Rajnoldi A., Putti M. C., Saitta M., Granchi D., Foa R., Schiro R., Castagni M., Valeggio C., Jankovic M., Miniero R., Paolucci P., Basso G. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia, relationship with the stage of differenciation and clinical significance. British Journal of Haematology 1991; 79: 40–43
   PubMed Web of Science ®Google Scholar
• Fink F. M., Koller U., Mayer H., Haas O. A., Grumayer-Panzer R., Urban C., Dengg K., Mutz I., Tüchler H., Gatterer-Menz I., Knapp W., Gadner H., For the Austrian Pediatric Oncology Group. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. Medical and Pediatric Oncology 1993; 21: 340–346
   PubMedGoogle Scholar
• Boucheix C., David B., Sebban C., Racadot E., Béné M.-C., Bernard A., Campos L., Jouault H., Sigaux F., Lepage E., Hervé P., Fière D., For the French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Immunophenotype of adult lymphoblastic leukemia, clinical parameters and outcome, an analysis of a prospective trial including 562 tested patients (LALA 87). Blood 1994; 84: 1603–1612
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. British Journal of Haematology 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Skubitz K., Balke J., Ball E., Bridges R., Buescher E. S., Campos L., Harvath L., Kerr M., Kniep B., Spitalnik P., Spitalnik S., Skubitz A., Thompson J., Wick M., Williams L. Report on the CD15 cluster workshop. Leucocyte typing IV. White cell differentiation antigens, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. K. Von dem Borne. Oxford University Press. 1989; 800–805
   Google Scholar
• Holowiecki J., Lutz D., Krzemien S., Graf F., Keleney G., Brugiatelly M., Callea V., Holowiecka B., Jagoda K., Ihle K., Kre I. Expression of CD15 antigen on leukemic cells—a new prognostic factor for ability to achieve complete remission and for survival in ANLL. Acute leukemias, vol 30, T. Büchner, G. Schellong, W. Hiddemann, D. Urbanitz, J. Ritter. Springer Verlag, Berlin 1987; 361–364
   Google Scholar
• Childs C. C., Hirsch-Ginsberg C., Walters R. S., Andersson B. S., Reuben J., Trujillo J. M., Cork A., Stass S. A., Freidereich E. J., Zipf T. F. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ALL), immunophenotypic, ultrastructural, cytogenetic and molecular characteristics. Leukemia 1989; 3: 777–783
   PubMed Web of Science ®Google Scholar
• Lauria F., Rasparodi D., Martinelli G., Ventura M. A., Farabegoli P., Tosi P., Testoni N., Visani G., Zaccaria A., Gamberi B., Cenacchi A., Tura S. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients, diagnostic and prognostic inplications. British Journal of Haematology 1994; 87: 286–292
   PubMed Web of Science ®Google Scholar
• Mirro J., Kitchingman G., Williams D., Lauzon G. J., Lin C. C., Callihan T., Zipf T. F. Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation. Blood 1986; 67: 689–697
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm G., Sing B., Rivera G. K., Schell M. J., Roberts W. M., Crist W. M., Mirro J. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198–202
   PubMed Web of Science ®Google Scholar
• Smith L. J., Curtis J. E., Messner H. A., Senn J. S., Furthmayr H., McCulloch E. A. Lineage infidelity in acute leukemia. Blood 1983; 61: 1138–1145
   PubMed Web of Science ®Google Scholar
• Thiel E., Kranz B. R., Raghavachar A., Bartran C. R., Löffler H., Messerer D., Ganser A., Ludwig W.-D., Büchner T., Hoelzer D. Prethymic phenotype and genotype of pre-T (CD7+/ER-) cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73: 1247–1258
   PubMed Web of Science ®Google Scholar
• Garand R., Voisin S., Papin S., Praloran V., Lenormand B., Favre M., Philip P., Bernier M., Vanhaecke D., Falkenrodt A., Béné M. C., Faure G. Characteristics of pro-T ALL subgroups, comparison with late T-ALL. Leukemia 1993; 7: 161–167
   PubMed Web of Science ®Google Scholar
• Skubitz K. M., Snook R. W. Monoclonal antibodies that recognize lactoN-fucopentaose III (CD15) react with the adhesion promoting glycoprotein family (LFA/HMac-1/GP150,95) and CRI on human neutrophils. Journal of Immunology 1987; 139: 1631–1639
   PubMed Web of Science ®Google Scholar
• Albrechtsen M., Kerr M. Characterization of human neutrophil glycoproteins expressing the CD15 differentiation antigen (3-fucosyl-N-acetyllactosamine). British Journal of Haematology 1989; 72: 312–320
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Chan L. C., Furley A. J. W., Watt S. M., Molgaard H. V. Lineage promiscuity in hematopoietic differenciation and leukemia. Blood 1986; 67: 1–11
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A., Mannoni P., Turner A. R., McGann L. E., Shaw A. R. E., Turc J.-M. Monoclonal antibody specific for granulocytic-lineage cells and reactive with human pluripotential and committed haemopoietic progenitor cells. British Journal of Haematology 1984; 58: 159–168
   PubMed Web of Science ®Google Scholar